No CrossRef data available.
Article contents
Selective serotonin re-uptake inhibitors. The clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertralineJohn P Feighner, W F Boyer, editors. Chichester: John Wiley & Sons, 1991. 168pp.
Published online by Cambridge University Press: 13 June 2014
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Book Reviews
- Information
- Copyright
- Copyright © Cambridge University Press 1992
References
1.Ansseau, M, Troisfontaines, B, Papart, P, von Frenckell, R. Compulsive personality as predictor of response to serotinergic antidepressants. BMJ 1991; 303: 760–61.CrossRefGoogle Scholar
2.Hoehn-Saric, R, Pearlson, GD, Harris, GJ, et al.Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiatry 1991; 148: 1243–45.Google ScholarPubMed
3.Möller, HJ. Fluoxetine: safety and side-effects in clinical practice. In: Freeman, HL, editor. The uses of fluoxetine in clinical practice. London: Royal Society of Medicine, 1991.Google Scholar
4.Reed, SM, Glick, JW. Fluoxetine and reactivation of the herpes simplex virus. Am J Psychiatry 1991; 148: 949–50.Google ScholarPubMed
5.Waite, J. Safety of 5-HT re-uptake inhibitors. Br J Psychiatry 1991; 159: 885.CrossRefGoogle Scholar
6.Clouston, T, 1881: “Fatten your patient and you will improve him in mind”. Quoted by Beveridge A. Thomas Clouston and the Edinburgh School of Psychiatry. In: Berrios, GF, Freeman, H, editors. 150 years of British psychiatry, 1841-1991. London: Gaskell, 1991.Google Scholar